#151568

Anti-TFF1 [PS2GE1]

Cat. #151568

Anti-TFF1 [PS2GE1]

Cat. #: 151568

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: Trefoil factor 1 (TFF1) also known as pS2/pNR2 Estrogen-regulated protein Ab2

Class: Monoclonal

Application: IHC ; IP

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-TFF1 [PS2GE1]
  • Research fields: Cancer;Cell biology;Genetics
  • Clone: PS2GE1
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 6.5 kDa
  • Reactivity: Human
  • Host: Mouse
  • Application: IHC ; IP
  • Description: pS2 is a cysteine-rich, 6.5kDa protein found in both oestrogen-dependent (breast tumours) and oestrogen-independent tissues (normal stomach mucosa). About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localisation to the Golgi apparatus. pS2 is primarily expressed in oestrogen receptor-positive breast tumours.
  • Immunogen: A synthetic 31-mer peptide from the C-terminus of human pS2 protein
  • Isotype: IgG1
  • Recommended controls: Normal stomach or breast carcinoma

Target Details

  • Target: Trefoil factor 1 (TFF1) also known as pS2/pNR2 Estrogen-regulated protein Ab2
  • Molecular weight: 6.5 kDa
  • Tissue cell line specificity: Normal stomach or breast carcinoma
  • Target background: pS2 is a cysteine-rich, 6.5kDa protein found in both oestrogen-dependent (breast tumours) and oestrogen-independent tissues (normal stomach mucosa). About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localisation to the Golgi apparatus. pS2 is primarily expressed in oestrogen receptor-positive breast tumours.

Applications

  • Application: IHC ; IP

Handling

  • Format: Liquid
  • Concentration: 0.9-1.1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Shipping at 4° C

References

  • Williams et al. 1996. Hum Pathol. 27(12):1259-66. PMID: 8958295.
  • Characterization of monoclonal antibodies raised to C-terminal peptides of pS2: a major trefoil peptide and motility factor expressed in adenocarcinomas and regions of mucosal injury.